Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance /
The current application of antibody-meditated targeted therapy against cancer has resulted in significant objective clinical responses, prolongation of survival and even cures. More than 20 mAbs have been approved for human use targeting a range of different cancers. However, a major drawback of mAb...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | SpringerLink (Online service) |
Otros Autores: | Bonavida, Benjamin (Editor ) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
Edición: | 1st ed. 2013. |
Colección: | Resistance to Targeted Anti-Cancer Therapeutics,
2 |
Temas: | |
Acceso en línea: | Texto Completo |
Ejemplares similares
-
Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications /
Publicado: (2013) -
Metastasis of Colorectal Cancer
Publicado: (2010) -
Naturally Occurring Antibodies (NAbs)
Publicado: (2012) -
Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy
Publicado: (2016) -
Bispecific Antibodies
Publicado: (2011)